enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. mTOR - Wikipedia

    en.wikipedia.org/wiki/MTOR

    The mammalian target of rapamycin (mTOR), [5] also referred to as the mechanistic target of rapamycin, and sometimes called FK506-binding protein 12-rapamycin-associated protein 1 (FRAP1), is a kinase that in humans is encoded by the MTOR gene. [6] [7] [8] mTOR is a member of the phosphatidylinositol 3-kinase-related kinase family of protein ...

  3. mTORC1 - Wikipedia

    en.wikipedia.org/wiki/MTORC1

    Rapamycin was the first known inhibitor of mTORC1, considering that mTORC1 was discovered as being the target of rapamycin. [83] Rapamycin will bind to cytosolic FKBP12 and act as a scaffold molecule, allowing this protein to dock on the FRB regulatory region (FKBP12-Rapamycin Binding region/domain) on mTORC1. [84]

  4. mTOR inhibitors - Wikipedia

    en.wikipedia.org/wiki/MTOR_inhibitors

    mTOR inhibitors are a class of drugs used to treat several human diseases, including cancer, autoimmune diseases, and neurodegeneration. They function by inhibiting the mammalian target of rapamycin (mTOR) (also known as the mechanistic target of rapamycin), which is a serine/threonine-specific protein kinase that belongs to the family of phosphatidylinositol-3 kinase (PI3K) related kinases ...

  5. PI3K/AKT/mTOR pathway - Wikipedia

    en.wikipedia.org/wiki/PI3K/AKT/mTOR_pathway

    Allosteric Akt inhibitors, highlighted by MK-2206, have been extensively evaluated in a clinical setting; Recently, additional allosteric Akt inhibitors have been identified. ARQ-092, is a potent pan-Akt inhibitor which can inhibit tumor growth preclinically and is currently in Phase I clinical studies.

  6. Sirolimus - Wikipedia

    en.wikipedia.org/wiki/Sirolimus

    Sirolimus is a relatively new medical therapy for the treatment of vascular malformations [25] in recent years, sirolimus has emerged as a new medical treatment option for both vascular tumors and vascular malformations, as a mammalian target of rapamycin (mTOR), capable of integrating signals from the PI3K/AKT pathway to coordinate proper cell ...

  7. Phosphoinositide 3-kinase - Wikipedia

    en.wikipedia.org/wiki/Phosphoinositide_3-kinase

    A group of more distantly related enzymes is sometimes referred to as class IV PI3Ks. It is composed of ataxia telangiectasia mutated (ATM), ataxia telangiectasia and Rad3 related (ATR), DNA-dependent protein kinase (DNA-PK) and mammalian target of rapamycin (mTOR). They are protein serine/threonine kinases.

  8. mTORC2 - Wikipedia

    en.wikipedia.org/wiki/MTORC2

    Rapamycin-insensitive companion of mTOR , mammalian stress-activated protein kinase interacting protein 1 , and protein observed with rictor 1 and 2 (Protor1/2) can only be found in mTORC2. [ 2 ] [ 3 ] Rictor has been shown to be the scaffold protein for substrate binding to mTORC2.

  9. Ragulator-Rag complex - Wikipedia

    en.wikipedia.org/wiki/Ragulator-Rag_complex

    The Ragulator-Rag complex is a regulator of lysosomal signalling and trafficking in eukaryotic cells, which plays an important role in regulating cell metabolism and growth in response to nutrient availability in the cell. [1] The Ragulator-Rag Complex is composed of five LAMTOR subunits, which work to regulate MAPK and mTOR complex 1. [2]